Nomansland, United Kingdom

Peter Rhodes


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 172(Granted Patents)


Location History:

  • Wiltshire, GB (1999)
  • Nomansland, Wiltshire SP5 2AY, GB (2000)
  • Nomansland, GB (2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Peter Rhodes

Introduction

Peter Rhodes is a notable inventor based in Nomansland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the area of nicotine treatment. With a total of 3 patents to his name, Rhodes has focused on developing innovative solutions to address nicotine-responsive conditions.

Latest Patents

One of his latest patents involves the intestinal absorption of nicotine to treat nicotine-responsive conditions. This invention features a delayed and sustained release composition of an additive and/or toxic agent, such as nicotine, which is delivered systemically in therapeutic amounts. The design aims to avoid the peak plasma levels that can lead to addiction and/or toxic side effects. The composition is primarily absorbed from the colon, providing a novel approach to nicotine delivery. Another patent includes pharmaceutical products containing a complex of an amide-type local agent, further showcasing his innovative work in the field.

Career Highlights

Throughout his career, Peter Rhodes has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research. His work has contributed to advancements in medical treatments and has had a positive impact on patient care.

Collaborations

Rhodes has collaborated with notable individuals in his field, including John Rhodes and William J Sandborn. These partnerships have likely enhanced the development and implementation of his innovative ideas.

Conclusion

Peter Rhodes is a distinguished inventor whose work in nicotine treatment has the potential to change lives. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…